搜索
Vera Therapeutics Inc
VERA添加自选
41.200USD
-1.460-3.42%
收盘 07/02, 13:00（美东）报价延迟15分钟
2.96B总市值
亏损市盈率 TTM
股东统计
更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
Avoro Capital Advisors LLC
8.20%
Longitude Capital Management Co., LLC
7.51%
T. Rowe Price Associates, Inc.
7.51%
BlackRock Institutional Trust Company, N.A.
5.89%
Deerfield Management Company, L.P.
5.66%
其他
65.22%
持股股东
持股股东
占比
Avoro Capital Advisors LLC
8.20%
Longitude Capital Management Co., LLC
7.51%
T. Rowe Price Associates, Inc.
7.51%
BlackRock Institutional Trust Company, N.A.
5.89%
Deerfield Management Company, L.P.
5.66%
其他
65.22%
股东类型
持股股东
占比
Hedge Fund
38.17%
Investment Advisor
35.87%
Investment Advisor/Hedge Fund
24.31%
Venture Capital
11.76%
Research Firm
3.43%
Individual Investor
0.99%
Bank and Trust
0.77%
Private Equity
0.49%
Pension Fund
0.37%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
453
86.22M
120.11%
+708.58K
2025Q4
419
73.02M
104.27%
-13.37M
2025Q3
391
70.61M
110.50%
-6.46M
2025Q2
381
74.82M
117.74%
-3.10M
2025Q1
382
72.82M
114.18%
-4.50M
2024Q4
363
73.64M
115.55%
+5.56M
2024Q3
344
64.32M
116.69%
-4.00M
2024Q2
326
63.69M
115.63%
-1.15M
2024Q1
280
61.43M
112.19%
+9.50M
2023Q4
210
49.91M
111.09%
+1.94M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Avoro Capital Advisors LLC
5.89M
8.25%
-321.11K
-5.17%
Dec 31, 2025
Longitude Capital Management Co., LLC
5.14M
7.21%
--
--
Oct 31, 2024
T. Rowe Price Associates, Inc.
5.39M
7.55%
+1.79M
+49.81%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
4.23M
5.93%
+431.94K
+11.37%
Dec 31, 2025
Deerfield Management Company, L.P.
4.06M
5.69%
+418.54K
+11.49%
Dec 31, 2025
Deep Track Capital LP
3.92M
5.5%
+1.10M
+39.00%
Mar 04, 2026
Kynam Capital Management LP
3.43M
4.81%
-594.75K
-14.77%
Dec 31, 2025
Eversept Partners, LP
3.07M
4.31%
+264.47K
+9.42%
Dec 31, 2025
Fidelity Management & Research Company LLC
2.89M
4.04%
+42.65K
+1.50%
Dec 31, 2025
Sofinnova Investments, Inc
2.79M
3.92%
--
--
Dec 31, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Virtus LifeSci Biotech Clinical Trials ETF
0.86%
State Street SPDR S&P Biotech ETF
0.81%
ALPS Medical Breakthroughs ETF
0.76%
Direxion Daily S&P Biotech Bull 3X Shares
0.37%
Optimize Strategy Index ETF
0.26%
ProShares Ultra Nasdaq Biotechnology
0.26%
Invesco Nasdaq Biotechnology ETF
0.18%
Fidelity Enhanced Small Cap ETF
0.15%
T Rowe Price Small-Mid Cap ETF
0.14%
iShares Biotechnology ETF
0.12%
查看更多
Virtus LifeSci Biotech Clinical Trials ETF
占比0.86%
State Street SPDR S&P Biotech ETF
占比0.81%
ALPS Medical Breakthroughs ETF
占比0.76%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.37%
Optimize Strategy Index ETF
占比0.26%
ProShares Ultra Nasdaq Biotechnology
占比0.26%
Invesco Nasdaq Biotechnology ETF
占比0.18%
Fidelity Enhanced Small Cap ETF
占比0.15%
T Rowe Price Small-Mid Cap ETF
占比0.14%
iShares Biotechnology ETF
占比0.12%